Recently, betulinic acid was identified as a highly selective inhibitor of
human melanoma growth and was reported to induce apoptosis in these cells.
We have investigated the growth-inhibitory properties of this compound alon
e and in combination with ionizing radiation in a panel of established huma
n melanoma cell lines as well as in normal human melanocytes. Betulinic aci
d strongly and consistently suppressed the growth and colony-forming abilit
y of all human melanoma cell lines investigated. In combination with ionizi
ng radiation the effect of betulinic acid on growth inhibition was additive
in colony-forming assays. Betulinic acid also induced apoptosis in human m
elanoma cells as demonstrated by Annexin V binding and by the emergence of
cells with apoptotic morphology. The growth-inhibitory action of betulinic
acid was more pronounced in human melanoma cell lines than in normal human
melanocytes. Notably, despite the induction of apoptosis, analysis of the e
xpression of Bcl-2 family members in betulinic-acid-treated cells revealed
that expression of the anti-apoptotic protein Mcl-1 was induced. Furthermor
e, the antiproliferative action of betulinic acid seemed to be independent
of the p53 status. The properties of betulinic acid make it an interesting
candidate, not only as a single agent but also in combination with radiothe
rapy. We conclude that the strictly additive mode of growth inhibition in c
ombination with irradiation suggests that the two treatment modalities may
function by inducing different cell death pathways or by affecting differen
t target cell populations.